Amphastar Pharmaceuticals, Inc. (AMPH) vs Harrow, Inc. (HROW)
- Amphastar Pharmaceuticals, Inc. AMPH 25.87 −2.08%
- Harrow, Inc. HROW 27.28 −5.11%
Amphastar Pharmaceuticals, Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Amphastar Pharmaceuticals, Inc. and Harrow, Inc. are of similar size ($1.1B and $1.1B). Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Amphastar Pharmaceuticals, Inc. trades at 14.9×. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against 1.02%. Amphastar Pharmaceuticals, Inc. has the higher net margin (10.8% vs −13.5%) and the higher return on invested capital (6.57% vs −0.77%). Across the 20 metrics below, Amphastar Pharmaceuticals, Inc. leads on 16 and Harrow, Inc. on 4.
Valuation
Profitability
| Metric | AMPH | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 47.68% | 73.28% | 53.94% |
| Operating margin | 15.66% | (1.00%) | 0.00% |
| Net margin | 10.76% | (13.51%) | 0.00% |
| Free cash flow margin | 20.94% | (4.75%) | 0.00% |
| Return on equity | 10.30% | (116.07%) | (0.40%) |
| Return on assets | 4.68% | (9.77%) | (3.32%) |
| Return on invested capital | 6.57% | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack